Artikkelit, joihin on yleisen käytön mandaatti - c ballardLisätietoja
YhteensäNIHRMRCNIHAlzheimers's UKWellcomeESRCNHMRCUK Research & InnovationCIHRDMTEuropean CommissionParkinson's UKBHFSwedish Research CouncilRCNNMRCEPSRCMichael J Fox FoundationDoDBBSRCGovernment of ItalyParkinson's Foundation, USARoyal Society UKMQ Mental Health ResearchARCKnut and Alice Wallenberg FoundationBlood Cancer UKGovernment of SpainASAPDam Foundation, NorwayVADFGSuomen AkatemiaaINSERMCancer Research UKDiabetes UKZonMwHealth Data Research, UKNordforskEDCTP
Ei saatavilla missään: 23
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
P Svenningsson, E Westman, C Ballard, D Aarsland
The Lancet Neurology 11 (8), 697-707, 2012
Mandaatit: Swedish Research Council
Dementia in Down's syndrome
C Ballard, W Mobley, J Hardy, G Williams, A Corbett
The Lancet Neurology 15 (6), 622-636, 2016
Mandaatit: US National Institutes of Health, National Institute for Health Research, UK
Update on vascular dementia
A Khan, RN Kalaria, A Corbett, C Ballard
Journal of geriatric psychiatry and neurology 29 (5), 281-301, 2016
Mandaatit: UK Medical Research Council
Course of neuropsychiatric symptoms in dementia: 5‐year longitudinal study
AO Vik‐Mo, LM Giil, C Ballard, D Aarsland
International journal of geriatric psychiatry 33 (10), 1361-1369, 2018
Mandaatit: National Institute for Health Research, UK
The effect of a multicomponent intervention on quality of life in residents of nursing homes: a randomized controlled trial (COSMOS)
BS Husebø, C Ballard, D Aarsland, G Selbaek, DD Slettebo, C Gulla, ...
Journal of the American Medical Directors Association 20 (3), 330-339, 2019
Mandaatit: Research Council of Norway, Royal Society UK
Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies
M Broadstock, C Ballard, A Corbett
Expert opinion on pharmacotherapy 15 (13), 1797-1810, 2014
Mandaatit: National Institute for Health Research, UK
Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer’s disease
AO Vik-Mo, J Bencze, C Ballard, T Hortobágyi, D Aarsland
Journal of Neurology, Neurosurgery & Psychiatry 90 (6), 728-730, 2019
Mandaatit: National Institute for Health Research, UK
Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry
D Enache, SM Fereshtehnejad, I Kåreholt, P Cermakova, ...
Acta Psychiatrica Scandinavica 134 (5), 430-440, 2016
Mandaatit: Swedish Research Council
Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies
AP Gatt, EL Jones, PT Francis, C Ballard, JM Bateman
Neuroscience letters 557, 177-180, 2013
Mandaatit: UK Medical Research Council
New therapeutic strategies for Lewy body dementias
L Velayudhan, D Ffytche, C Ballard, D Aarsland
Current neurology and neuroscience reports 17, 1-9, 2017
Mandaatit: National Institute for Health Research, UK
An online investigation of the relationship between the frequency of word puzzle use and cognitive function in a large sample of older adults
H Brooker, KA Wesnes, C Ballard, A Hampshire, D Aarsland, Z Khan, ...
International journal of geriatric psychiatry 34 (7), 921-931, 2019
Mandaatit: National Institute for Health Research, UK
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in …
C Ballard, A Thomas, S Gerry, LM Yu, D Aarsland, C Merritt, A Corbett, ...
Journal of the American Medical Directors Association 16 (4), 316-322, 2015
Mandaatit: National Institute for Health Research, UK
Neuropsychiatric symptoms and functional decline in Alzheimerʼs disease and Lewy body dementia
MG Borda, D Aarsland, DA Tovar‐Rios, LM Giil, C Ballard, MC Gonzalez, ...
Journal of the American Geriatrics Society 68 (10), 2257-2263, 2020
Mandaatit: National Institute for Health Research, UK
Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies
M Johnson, A Ekonomou, C Hobbs, CG Ballard, RH Perry, EK Perry
Hippocampus 21 (10), 1126-1136, 2011
Mandaatit: Dunhill Medical Trust, UK
Associations between ZnT3, tau pathology, agitation, and delusions in dementia
DR Whitfield, PT Francis, C Ballard, G Williams
International journal of geriatric psychiatry 33 (8), 1146-1152, 2018
Mandaatit: Alzheimers's UK, UK Medical Research Council, National Institute for Health …
Increased neural progenitors in individuals with cerebral small vessel disease
A Ekonomou, M Johnson, RH Perry, EK Perry, RN Kalaria, SL Minger, ...
Neuropathology and applied neurobiology 38 (4), 344-353, 2012
Mandaatit: US National Institutes of Health
Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementia
E Clarke, C Jantrachotechatchawan, Y Buhidma, M Broadstock, L Yu, ...
Neurochemistry international 129, 104502, 2019
Mandaatit: Alzheimers's UK, UK Medical Research Council
Novel pharmaceuticals in the treatment of psychosis in Parkinson’s disease
M Broadstock, C Ballard, A Corbett
Expert review of clinical pharmacology 7 (6), 779-786, 2014
Mandaatit: National Institute for Health Research, UK
Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer disease
B Creese, A Corbett, E Jones, C Fox, C Ballard
Journal of the American Medical Directors Association 15 (12), 934-937, 2014
Mandaatit: National Institute for Health Research, UK
Measuring the effectiveness of safety warnings on the risk of stroke in older antipsychotic users: a nationwide cohort study in two large electronic medical records databases …
J Sultana, A Fontana, F Giorgianni, S Tillati, C Cricelli, A Pasqua, ...
Drug safety 42, 1471-1485, 2019
Mandaatit: Government of Italy
Tietokoneohjelma arvioi ja määrittää julkaisu- ja rahoitustiedot automaattisesti